ArticleInternal medicine (Tokyo, Japan)2026
Acute Myeloid Leukemia with an FMS-like Tyrosine Kinase 3-tyrosine Kinase Domain Mutation Developing Gilteritinib-induced Differentiation Syndrome.
Chiaki Kubara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.